Measles kills more than 200,000 people each year – mostly children aged under five – although a cheap and effective vaccine has existed for over half a century.

In 2019, there were 870,000 cases of measles reported – the highest number in nearly a quarter of a century – and nearly 208,000 deaths. The disease is extremely contagious, yet easily preventable with two doses of a vaccine. MSF has vaccinated over 30 million children against measles since 2006. Outbreaks are fuelled by weak public immunisation systems and low vaccination coverage, including in areas of conflict and among high numbers of people living in close quarters, such as refugee camps.

 

Quick facts about measles

Measles_disease

5 minutes to understand

MEASLES IS A HIGHLY CONTAGIOUS DISEASE CAN CAUSE DEADLY EPIDEMICS.

The World Health Organization estimates that measles cases in Africa rose 700 per cent between 2018 and 2019.

In low-income countries, when measles is combined with malnutrition or malaria, it’s effects can be devastating. But, thanks to a safe, cheap and effective vaccine, measles is a preventable disease.

In Chad, Niger, and Nigeria, supply and cold chain issues and a lack of staff and resources have all affected recent vaccination campaigns. As a result, epidemics that broke out in 2018 continue to claim lives.

Taking action in contexts like these necessitates a series of strategic decisions.

DONATE NOW
 
Cholera

MSF warns of large-scale humanitarian disaster in northeastern Nigeria

Press Release 27 Jul 2016
 
Measles

MSF alert! Five epidemics to watch in 2016

Latest News 20 Jun 2016
 
Influx of Syrians into Domeez Camp, Iraq
Measles

Syrian measles epidemic signals growing humanitarian needs

Press Release 18 Jun 2016
 
Niger: MSF response to meningitis, measles and cholera outbreaks
Measles

Niger: MSF tackles two epidemics

Latest News 14 Jun 2016
 
Malaria

Thousands of South Sudanese refugees living in deplorable conditions in Eastern Central African Republic

Press Release 11 May 2016
 
Cholera

Bringing down barriers to access lower prices of new vaccines

Press Release 3 May 2016